BIOMAT Database Logo BIOMAT Database Logo

[Obstructive respiratory diseases. Comparisons of dose effectiveness of Fenoterol (Berotec) given in diverse oral administration forms]. 1979

B Hertwig

UI MeSH Term Description Entries
D008173 Lung Diseases, Obstructive Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent. Obstructive Lung Diseases,Obstructive Pulmonary Diseases,Lung Disease, Obstructive,Obstructive Lung Disease,Obstructive Pulmonary Disease,Pulmonary Disease, Obstructive,Pulmonary Diseases, Obstructive
D008297 Male Males
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D004983 Ethanolamines AMINO ALCOHOLS containing the ETHANOLAMINE; (-NH2CH2CHOH) group and its derivatives. Aminoethanols
D005260 Female Females
D005280 Fenoterol A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic. Berotec,Berotek,Fenoterol Hydrobromide,Fenoterol Hydrochloride,Partusisten,Phenoterol,Th-1165a,p-Hydroxyphenyl-orciprenaline,p-Hydroxyphenylorciprenaline,Hydrochloride, Fenoterol,Th 1165a,Th1165a,p Hydroxyphenyl orciprenaline,p Hydroxyphenylorciprenaline
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

B Hertwig
[Fenoterol suppositories in obstructive respiratory diseases].
June 1979, Therapie der Gegenwart,
B Hertwig
Fenoterol (Berotec) in asthma.
March 1978, Drug and therapeutics bulletin,
B Hertwig
Open assessment of fenoterol (Berotec)
April 1979, The Medical journal of Australia,
B Hertwig
[The oral application of berotec in the therapy of obstructive airway diseases].
March 1978, Fortschritte der Medizin,
B Hertwig
The bronchodilator effect of fenoterol (Berotec).
March 1975, The New Zealand medical journal,
B Hertwig
[Dose-effect relation of oral orciprenaline in obstructive respiratory diseases].
August 1970, Arzneimittel-Forschung,
B Hertwig
A dose-response study on fenoterol (Berotec) solution by inhalation in asthmatic children.
January 1983, Developmental pharmacology and therapeutics,
B Hertwig
Open assessment of fenoterol (Berotec) in severe asthmatics in general practice.
September 1978, The Medical journal of Australia,
B Hertwig
[Pathomorphologic principles in various forms of obstructive respiratory tract diseases].
January 1990, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
B Hertwig
[Comparative studies on the oral therapy of obstructive respiratory tract diseases with clenbuterol, fenoterol and depot-orciprenaline (double-blind study)].
January 1978, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
Copied contents to your clipboard!